Wolters Kluwer (Euronext: WKL) announces today that after a very successful tenure as the CEO and Chair of the Executive Board of Wolters Kluwer, Nancy McKinstry has decided to retire in February 2026. At the Annual General Meeting of Shareholders on May 15, 2025, the Supervisory Board will nominate Stacey Caywood, current CEO of Wolters Kluwer Health, as a member of the Executive Board, with the intention of appointing her as CEO of Wolters Kluwer in February 2026.
“On behalf of the entire Supervisory Board, I would like to extend our heartfelt congratulations to Nancy McKinstry on her well-deserved retirement next year. Nancy's visionary leadership and unwavering dedication have been instrumental in driving Wolters Kluwer’s success, which has been recognized in many ways but perhaps most notably by a more than tenfold increase in the company’s market capitalization during her time as CEO. We are immensely grateful for the strong foundation she has built at Wolters Kluwer and for her commitment to ensuring an orderly and seamless transition, said Ann Ziegler, Chair of the Wolters Kluwer Supervisory Board.
“We are delighted to nominate Stacey Caywood as Wolters Kluwer CEO, effective February 2026,” Ms. Ziegler added. “Stacey's successful track record leading two of our largest divisions, her deep understanding of our business, and her active role in developing the group’s 2025-2027 strategic plan make her the ideal candidate to lead the company into the future. For over thirty years, Stacey has held various leadership roles within the company, and we have full confidence in her ability to continue Wolters Kluwer’s legacy of sustainable value creation through excellence and innovation. We look forward to working closely with Stacey and supporting her in this new role.”
“It has been an honor and privilege to lead Wolters Kluwer through decades of transformation as the market has evolved, and I am committed to ensuring the company’s continued strength and relevance,” said Ms. McKinstry. “I am deeply grateful to the Board and my past and present colleagues for their support throughout my tenure. We have a strong foundation in place and, with Stacey, an extraordinarily talented and experienced successor. Stacey’s track record as a leader, her customer-focused approach, and her deep knowledge of our company gives me full confidence that Wolters Kluwer will be in excellent hands under her leadership. I am dedicated to ensuring a seamless transition over the next year.” Stacey Caywood, CEO of Wolters Kluwer Health since 2020, has led the further evolution and development of Wolters Kluwer’s healthcare solutions, ensuring medical and nursing professionals around the world can benefit from advanced clinical technology and evidence-based data and insights. Previously, as CEO of Wolters Kluwer Legal & Regulatory, she led a strategic transformation across Europe and the U.S., returning the business to organic growth. Ms. Caywood is a seasoned executive with extensive experience; she excels in business transformation, digital revenue growth, and innovation across legal, compliance, and healthcare markets. Her expertise spans strategy execution, portfolio management and M&A, product innovation, and commercial excellence.
After appointment by Wolters Kluwer's shareholders at the Annual General Meeting on May 15, 2025, the Executive Board of Wolters Kluwer N.V. will consist of Nancy McKinstry (CEO, until February 2026), Kevin Entricken (CFO) and Stacey Caywood.
